person

Seamus H.

Country
Ireland
Department
Gastroenterology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
22
Sites with multiple studies

Has run more than one trial at 22 of 64 partner sites.

Specializations

Inflammatory Bowel Disease

The investigator specializes in treating pediatric patients with inflammatory bowel diseases, with particular focus on ulcerative colitis and Crohn's disease. Their research centers on innovative therapeutic approaches for managing moderate to severe cases in young patients.

  • Pediatric Ulcerative Colitis
  • Pediatric Crohn's Disease
  • Advanced Biological Therapies

Their expertise extends to evaluating novel treatment modalities and therapeutic agents for pediatric IBD management.

Pediatric Gastroenterology

The investigator focuses on developing treatment strategies for moderately to severely active gastrointestinal conditions in children and adolescents. Their work encompasses the study of various therapeutic interventions for pediatric digestive disorders.

  • Pediatric Gastrointestinal Disorders
  • Disease Remission Strategies
  • Long-term Disease Management

Their research includes evaluating maintenance therapies and long-term treatment outcomes in pediatric populations.

Clinical Pharmacology

The investigator studies therapeutic pharmacology in pediatric populations, with emphasis on understanding medication effectiveness and maintaining sustained clinical responses in young patients with inflammatory conditions.

  • Pediatric Drug Studies
  • Treatment Response Assessment
  • Therapeutic Drug Monitoring

Their work involves evaluating novel therapeutic agents and their applications in pediatric gastroenterology.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.